Abstract
IntroductionMagnetic Resonance Spectroscopy (MRS) biomarkers have been used for prognostication of neurodevelopmental outcomes in newborns affected by Hypoxic Ischaemic Encephalopathy (HIE). Previous studies have evaluated these markers primarily in non-cooled...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Archives of disease in childhood. Fetal and neonatal edition
Paper Title
Journal
Date
